BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3263955)

  • 1. Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids.
    Schuurmans AL; Bolt J; Voorhorst MM; Blankenstein RA; Mulder E
    Int J Cancer; 1988 Dec; 42(6):917-22. PubMed ID: 3263955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP.
    Berns EM; de Boer W; Mulder E
    Prostate; 1986; 9(3):247-59. PubMed ID: 2946029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen stimulated elevation in androgen receptor levels is inhibited by the synthetic glucocorticoid triamcinolone acetonide.
    Syms AJ; Norris JS; Smith RG
    Biochem Biophys Res Commun; 1983 Nov; 116(3):1020-5. PubMed ID: 6606427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid hormone regulation of prostatic acid phosphatase expression in cultured human prostatic carcinoma cells.
    Schulz P; Bauer HW; Fittler F
    Biol Chem Hoppe Seyler; 1985 Nov; 366(11):1033-9. PubMed ID: 3878148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the cytosolic androgen receptor in striated muscle by sex steroids.
    Rance NE; Max SR
    Endocrinology; 1984 Sep; 115(3):862-6. PubMed ID: 6611254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumor cell LNCaP.
    Schuurmans AL; Bolt J; Mulder E
    Prostate; 1988; 12(1):55-63. PubMed ID: 3258066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: high affinity for progestagenic and estrogenic steroids.
    Veldscholte J; Voorhorst-Ogink MM; Bolt-de Vries J; van Rooij HC; Trapman J; Mulder E
    Biochim Biophys Acta; 1990 Apr; 1052(1):187-94. PubMed ID: 2322591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the cytosol androgen receptor of the human prostate.
    Wilbert DM; Griffin JE; Wilson JD
    J Clin Endocrinol Metab; 1983 Jan; 56(1):113-20. PubMed ID: 6183286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characterization of the androgen receptor from hyperplastic human prostate.
    Murthy LR; Chang CH; Rowley DR; Scardino PT; Tindall DJ
    Prostate; 1984; 5(6):567-79. PubMed ID: 6208540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor-mediated growth and epidermal growth factor receptor induction in the human prostate cell line LNCaP.
    Schuurmans AL; Bolt J; Mulder E
    Urol Int; 1989; 44(2):71-6. PubMed ID: 2728128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgenic and antiandrogenic control on epidermal growth factor, epidermal growth factor receptor, and androgen receptor expression in human prostate cancer cell line LNCaP.
    Ravenna L; Lubrano C; Di Silverio F; Vacca A; Felli MP; Maroder M; D'Eramo G; Sciarra F; Frati L; Gulino A
    Prostate; 1995 Jun; 26(6):290-8. PubMed ID: 7784269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of androgen receptor in cytosols from normal, benign hypertrophic and cancerous human prostates.
    Shimazaki J; Hikage T; Sato R; Kodama T; Ito H
    Endocrinol Jpn; 1981 Dec; 28(6):725-34. PubMed ID: 6179768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of steroid receptors in human prostate using mibolerone.
    Murthy LR; Johnson MP; Rowley DR; Young CY; Scardino PT; Tindall DJ
    Prostate; 1986; 8(3):241-53. PubMed ID: 2422638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP.
    Montgomery BT; Young CY; Bilhartz DL; Andrews PE; Prescott JL; Thompson NF; Tindall DJ
    Prostate; 1992; 21(1):63-73. PubMed ID: 1379363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a [3H]methyltrienolone (R1881) binding protein in rat liver cytosol.
    Levinson DJ; Decker DE
    J Steroid Biochem; 1985 Feb; 22(2):211-9. PubMed ID: 3872380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of androgen receptors in a transplantable human prostatic adenocarcinoma (PC-82).
    Brinkmann AO; Bolt J; van Steenbrugge GJ; Kuiper GG; de Boer W; Mulder E
    Prostate; 1987; 10(2):133-43. PubMed ID: 2951663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones.
    Schuurmans AL; Bolt J; Veldscholte J; Mulder E
    J Steroid Biochem Mol Biol; 1991; 40(1-3):193-7. PubMed ID: 1958520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor in rat skeletal muscle: characterization and physiological variations.
    Michel G; Baulieu EE
    Endocrinology; 1980 Dec; 107(6):2088-98. PubMed ID: 6968675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP.
    Joly-Pharaboz MO; Soave MC; Nicolas B; Mebarki F; Renaud M; Foury O; Morel Y; Andre JG
    J Steroid Biochem Mol Biol; 1995 Oct; 55(1):67-76. PubMed ID: 7577722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroids inversely affect the biosynthesis and secretion of human prostatic acid phosphatase and prostate-specific antigen in the LNCaP cell line.
    Henttu P; Vihko P
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):349-60. PubMed ID: 1373297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.